Browse every story filed under this topic, curated from trusted publishers around the world.
Elon Musk clashes with OpenAI’s attorney on his third day of testimony at high-stakes trial
Read full story →
The cost of inefficiencies in clinical trials
Estimates suggest fragmented technology can raise clinical trial costs by 45%, but a unified approach to clinical data management can …
Bambusa completes enrolment in BBT001 Phase Ib/IIa trial for atopic dermatitis
Bambusa Therapeutics has completed patient enrolment in its Phase Ib/IIa trial evaluating BBT001 to treat moderate-to-severe atopic dermatitis. The post …
How Shivon Zilis Operated as Elon Musk’s OpenAI Insider
Messages presented at trial reveal how Zilis, the mother of four of Musk’s children, acted as an intermediary between him …
4 things you missed from Day 4 of the Musk v. Altman trial
Elon Musk faced another day of cross-examination. Jared Birchall, Musk's wealth manager, was the next witness called in the blockbuster …
Elon Musk's 7 biggest stumbles on the stand at OpenAI trial
Elon Musk spent three days testifying as the first witness in his trial against OpenAI.
STAT+: Hair-raising trial results, and Servier’s M&A wishlist
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The …
Musk v. Altman Kicks Off, DOJ Guts Voting Rights Unit, and Is the AI Job Apocalypse Overhyped?
In this episode of Uncanny Valley, we get into how the Elon Musk-Sam Altman trial goes way beyond their rivalry …
It’s Not My Money(ball) 2026: The Devil You Know
Examining the upcoming trial of Emmanuel Clase, a fradulent yogurt company, and updates to previous entries.
If OpenAI Loses This Trial, It Could Effectively Be Eliminated in Its Current Form
The timing of Elon Musk's lawsuit couldn't be worse for OpenAI. The post If OpenAI Loses This Trial, It Could …
WHCA shooting suspect agrees to remain detained ahead of trial
The alleged gunman at the White House Correspondents’ Association (WHCA) dinner last weekend will remain in detention ahead of trial …
STAT+: Five-way obesity drug is super effective — in mice
A 'quintuple agonist,' Alector halts it Alzheimer's trial, and more biotech news from The Readout
Park & Ride trial: Newcastle Great Park
This trial is a result of feedback shared at our recent Sustainable Travel Workshop. Fans asked for even more accessible, …
Patient death puts Newron’s late-stage schizophrenia trial on ice
An independent international safety monitoring board has given the ENIGMA-TRS 1 trial the go-ahead to continue as planned in schizophrenia. …
First patient dosed in Newleos’ Phase Ib trial of NTX-2001
Newleos Therapeutics has dosed the first participant in its Phase Ib clinical study evaluating NTX-2001, a partial agonist of TAAR1, …
Pfizer hoping for earlier Elrexfio use in RRMM after Phase III trial
Pfizer's study met its primary endpoint of PFS when Elrexfio was used as a second-line therapy in RRMM. The post …
Precision begins patient enrolment for FUNCTION-DMD trial
Precision BioSciences has begun patient enrolment for its Phase I/II FUNCTION-DMD clinical trial of PBGENE-DMD for DMD. The post Precision …
Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
Boehringer Ingelheim reports significant reductions in weight
Indonesia launches QRIS payments with China
QRIS in China was ready for launch after a trial recorded 1.64 million transactions worth 556 billion rupiah (US$32.2 million).
How Elon Musk Squeezed OpenAI: They 'Are Gonna Want to Kill Me’
Tensions flared on the third day of trial in Musk v. Altman as OpenAI’s lawyers cross-examined Musk.
You've seen all articles for #trial.
Check back
soon
for new stories.